ResearcherSeoul National UniversityNo recent work listed

Yong-Tae Kim

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5111773378. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper

Papers 1

Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells. Last author DOI 10.21873/anticanres.12624 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Woo Hyun Paik · 1 shared paper, 2018 · strength 0.09
- Paper Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells. DOI 10.21873/anticanres.12624 ↗
Nayoung Kim · 1 shared paper, 2018 · strength 0.09
- Paper Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells. DOI 10.21873/anticanres.12624 ↗
Sang Hyub Lee · 1 shared paper, 2018 · strength 0.09
- Paper Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells. DOI 10.21873/anticanres.12624 ↗
Ji Kon Ryu · 1 shared paper, 2018 · strength 0.09
- Paper Fisetin Enhances the Cytotoxicity of Gemcitabine by Down-regulating ERK-MYC in MiaPaca-2 Human Pancreatic Cancer Cells. DOI 10.21873/anticanres.12624 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.